Vitafoods Europe
Rousselot to Showcase Science on Nextida Collagen Peptides and Glucose Control/GLP-1
Emerging research found that this specific formulation can support the body’s glucose regulation mechanism, potentially reducing the effects of sugar crashes.
By: Mike Montemarano
Associate Editor, Nutraceuticals World
Photo: Fle Life Fle World | Adobe Stock
Booth 3K119
Rousselot, Darling Ingredients’ collagen and gelatin brand, will introduce Nextida GC at Vitafoods Europe, following its initial U.S. launch in 2024. Nextida GC is a specific collagen peptide formulation targeting glucose control and GLP-1.
“As consumer awareness of glucose management and GLP-1 increases, we are excited to present Nextida GC with new clinical data in Barcelona,” said Florencia Moreno Torres, global business development manager for health and nutrition at Rousselot. “Nextida GC offers a unique approach in the nutraceutical space to help brands address the evolving metabolic health market, the natural way.”
Nextida GC is designed to maintain balanced post-meal glucose levels in healthy individuals by leveraging the body’s natural GLP-1 response. In pre-clinical and human clinical studies, the ingredient appeared to enhance glucose regulation. Glucose control is important to avoid sugar crashes and their associated consequences, like cravings, overeating, and fatigue.
Visitors to the Rousselot booth can discuss Nextida GC application prototypes and gather first-hand insights in two expert-led sessions at the New Ingredients Theater (3G266):
- “GLP-1 Nutrition, the key upcoming category in the nutraceutical world” by Florencia Moreno Torres, global business development manager of health and nutrition at Rousselot, on May 20 at 2:30-2:55 p.m. CEST
- “Nextida GC: the science behind boosting natural GLP-1 with collagen,” by Catarina Ferreira da Silva, PhD, science integration manager at Rousselot, on May 21 at 2:30-2:55 p.m. CEST
